Evidence map›Paper›PMID 24782840›Full record

ArticleFrontiers in microbiology2014

New edge of antibiotic development: antimicrobial peptides and corresponding resistance.

Nadia S Parachin, Octavio L Franco

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. An antibody-drug conjugate active against antibiotic-resistantProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. A Review: The Antiviral Activity of Cyclic Peptides.International journal of peptide research and therapeutics · 2023
    Review
  3. Article
  4. Article
  5. Review
  6. Frontiers in microbiology · 2022
    Article
  7. Genome-Wide Identification ofFrontiers in plant science · 2020
    Article
  8. Antimicrobial peptides fromRSC advances · 2019
    Review
  9. Article
  10. Arminin 1a-C, a novel antimicrobial peptide from ancient metazoanDrug design, development and therapy · 2018
    Article
  11. Antibiotic resistance: a rundown of a global crisis.Infection and drug resistance · 2018
    Review
  12. Review
  13. Review
  14. Antimicrobial lipopeptide tridecaptin A1 selectively binds to Gram-negative lipid II.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  15. Article
  16. Recent Developments in Antimicrobial Polymers: A Review.Materials (Basel, Switzerland) · 2016
    Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nadia S ParachinGrupo engenharia de Biocatalisadores, Departamento de Biologia Celular, Instituto de Ciências Biológicas, Universidade de Brasília Brasília, Brazil ; Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Centro de Análises Proteômicas e Bioquímicas, UCB Brasília, Brazil.
Octavio L FrancoPrograma de Pós-Graduação em Ciências Genômicas e Biotecnologia, Centro de Análises Proteômicas e Bioquímicas, UCB Brasília, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial peptideantitumoral peptidehost defense peptidemicrobial resistance

Identifiers

PMID24782840
PMCPMC3986519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.